CFMS — ConforMIS Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $17.80m
- $12.26m
- $62.05m
Annual cashflow statement for ConforMIS, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -43.4 | -28.5 | -24.3 | -2.41 | -50.5 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 14.9 | 6.07 | 2.13 | 5.35 | 6.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.783 | 15.3 | -0.517 | -15.6 | -9.81 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -25.2 | -2.84 | -18.3 | -8.4 | -50.2 |
| Capital Expenditures | -4.06 | -2.93 | -3.25 | -2.3 | -1.92 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 19.7 | 7.25 | 0 | — | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 15.6 | 4.32 | -3.25 | -2.3 | -1.92 |
| Financing Cash Flow Items | -0.225 | -1.66 | -0.01 | -1.88 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.66 | 8.53 | 23.8 | 82.8 | 0 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.97 | 10 | 2.28 | 72 | -52 |